BioCryst Pharmaceuticals, Inc.

BO1.F·Frankfurt·Healthcare
Compare
6.98−0.04 (−0.54%)today
As of Oct 21, 8:04 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close7.02
Open6.98
Day range—
52-week range5.1810.19
Off day high0.00%
Off 52-week high−31.45%
Volume14.00
Avg. volume (3M)70.00
Market cap1.78B
EPS (TTM)-1.20
Forward P/E-9.44
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.55
Shares outstanding255.54M
Short interest—
Earnings dateAug 5, 2026
Analyst target—
Profit margin−40.90%

Against its peers

Compare in full ›
BO1.F ALVO NBIX KNSA AKBA BIOA
Market cap 1.78B 1.83B 14.35B 6.20B 162.72M 252.43M
P/E (TTM) — — 20.7 80.3 — —
Forward P/E -9.4 22.3 11.8 49.1 -1.6 -2.2
Price/book -4.4 -9.6 3.9 9.5 6.4 0.7
Dividend yield — — — — — —
1-year change +18.46% −37.79% +0.37% +113.80% −79.33% −8.10%
Today −0.54% +0.39% −0.58% −4.45% −5.00% −1.08%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All BO1.F news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

In the news

1mentions in 30 days
1with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.